OrbiMed Genesis GP LLC's Net Worth
$0
Who is OrbiMed Genesis GP LLC?
OrbiMed Genesis GP LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adicet Bio, Inc., Keros Therapeutics, Inc., PMV Pharmaceuticals, Inc., Theseus Pharmaceuticals, Inc., Janux Therapeutics, Inc., Edgewise Therapeutics, Inc., Kinnate Biopharma Inc., Ikena Oncology, Inc., Sierra Oncology, Inc., Galecto, Inc., Decibel Therapeutics, Inc., Compass Therapeutics, Inc., Terns Pharmaceuticals, Inc., Enliven Therapeutics, Inc., Disc Medicine, Inc., scPharmaceuticals Inc., Pandion Therapeutics Holdco LLC, ALPINE IMMUNE SCIENCES, INC., and LogicBio Therapeutics, Inc..
SEC CIK
OrbiMed Genesis GP LLC's CIK is 0001808744
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Adicet Bio, Inc. (ACET) Snapshot price: $1.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.01% | 3.13M |
$2.40 | $7,500,000.00 | 9.77M |
Jan 25
| |||
Form 4
| +12.10% | 875K |
$2.09 | $1,828,750.00 | 8.11M |
Jun 27
| |||
Form 4
| +765.30% | 214.28K |
$14.00 | $2,999,990.00 | 242.28K |
Dec 10
| |||
| No matching records found | |||||||||
Keros Therapeutics, Inc. (KROS) Snapshot price: $52.51
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -19.70% | -250.00K |
$44.01 | -$11,002,500.00 | 1.02M |
Aug 13
| |||
Form 4
| +170.39% | 1.27M |
$16.00 | $6,003,200.00 | 2.01M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PMV Pharmaceuticals, Inc. (PMVP) Snapshot price: $1.6588
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -87.79K |
$2.23 | -$195,762.78 |
0
|
Nov 22
| |||
Form 4
| -23.02% | -26.25K |
$15.93 | -$418,210.29 | 87.79K |
May 26
| |||
Form 4
| -100.00% | -474.50K |
$21.63 | -$10,264,415.00 |
0
|
Mar 29 - Mar 31
| |||
Form 4
|
∞
| 7.06M |
$18.00 | $8,550,000.00 | 7.06M |
Sep 25 - Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theseus Pharmaceuticals, Inc. (THRX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -17.71M |
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +2.78% | 479.93K |
$3.05 | $1,463,792.60 | 17.71M |
Jul 17
| |||
Form 4
| +1.16% | 192K |
$5.21 | $1,000,320.00 | 16.73M |
Nov 7
| |||
Form 4
| +0.97% | 158.42K |
$9.97 | $1,578,717.49 | 16.54M |
Jan 19 - Jan 21
| |||
Form 4
| +0.27% | 44.72K |
$9.90 | $442,750.42 | 16.38M |
Jan 11 - Jan 13
| |||
Form 4
|
∞
| 16.84M |
$16.00 |
—
| 16.84M |
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Janux Therapeutics, Inc. (JANX) Snapshot price: $42.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.60% | -40.40K |
$20.30 | -$820,120.00 | 2.49M |
Dec 29
| |||
Form 4
| -4.51% | -119.40K |
$19.00 | -$2,268,600.00 | 2.53M |
Dec 21
| |||
Form 4
| -12.93% | -393.30K |
$19.07 | -$7,500,231.00 | 2.65M |
Dec 16
| |||
Form 4
|
∞
| 3.04M |
$17.00 |
—
| 3.04M |
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||